Alps Advisors Inc Baxter International Inc Transaction History

Alps Advisors Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$63.83 - $80.0 $967,598 - $1.21 Million	15,159 New	15,159 $974,000
Q3 2021 Nov 15, 2021	SELL	$73.77 - $83.61 $316,915 - $359,188	-4,296 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$76.38 - $86.03 $328,128 - $369,584	4,296 New	4,296 $362,000
Q3 2020 Nov 04, 2020	SELL	$78.33 - $90.73 $196,451 - $227,550	-2,508 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$78.66 - $94.14 $879,576 - $1.05 Million	-11,182 Reduced 81.68%	2,508 $216,000
Q1 2020 May 06, 2020	SELL	$71.57 - $93.3 $208,626 - $271,969	-2,915 Reduced 17.55%	13,690 $1.11 Million
Q4 2019 Feb 07, 2020	SELL	$76.7 - $88.45 $51,542 - $59,438	-672 Reduced 3.89%	16,605 $1.39 Million
Q3 2019 Nov 04, 2019	SELL	$81.4 - $89.78 $596,173 - $657,548	-7,324 Reduced 29.77%	17,277 $1.51 Million
Q2 2019 Aug 07, 2019	SELL	$73.44 - $82.41 $221,127 - $248,136	-3,011 Reduced 10.9%	24,601 $2.02 Million
Q1 2019 May 01, 2019	BUY	$64.48 - $81.31 $1.78 Million - $2.25 Million	27,612 New	27,612 $2.25 Million

970

450M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.4B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.